New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Inhalable Nanobodies Can Cure Coronavirus

You may soon be able to ‘vape’ coronavirus away with inhalable nanobodies that kill the virus.

A recent Interesting Engineering article discussed a new method for curing and preventing coronavirus: inhalable nanobodies. Though the concept hasn’t been tested in humans yet, trials on Syrian hamsters were extremely promising. The therapy is called the Pittsburgh inhalable Nanobody 21 (aka PiN-21), and it offers a needleless alternative to the monoclonal antibodies that are typically used to treat early infections.

The new nanobody-based substance is inhaled like a vapor, but can work regardless of its entry point to the respiratory system. It employs single-domain antibody fragments, which are cheaper to produce than traditional monoclonal antibodies. The treatment can also be aerosolized to create a whole-body exposure, which would enable rapid inoculation of populations to protect against COVID-19 coronavirus and its variants. 

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts